Neoadjuvant chemotherapy vs, radiotherapy alone for superior vena cava syndrome (SVCS) due to non-small cell lung cancer (NSCLC): Preliminary results of randomized phase II trial

被引：6
|
作者：
Pereira, JR
Martins, SJ
Ikari, FK
Nikaedo, SM
Gampel, O
机构：
[1] Arnaldo Vieira Carvalho Canc Inst, Sao Paulo, Brazil
[2] Paulista Lung Canc Treatment Grp, Sao Paulo, Brazil
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81452-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1032
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [41] A RANDOMIZED DISCONTINUATION PHASE II TRIAL OF RIDAFOROLIMUS IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH KRAS MUTATIONS
    Riely, Gregory J.
    Brahmer, Julie
    Planchard, David
    Crino, Lucio
    Doebele, Robert C.
    Maz Lopez, Luis
    Gettinger, Scott N.
    Schumann, Christian
    Guan, Shanghong
    Atkins, B.
    Ebbinghaus, S.
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S608 - S609
  • [42] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC).
    Lynch, TJ
    Lilenbaum, R
    Bonomi, P
    Ansari, R
    Govindan, R
    Janne, PA
    Hanna, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 637S - 637S
  • [43] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)
    Hanna, N
    Bonomi, P
    Lynch, T
    Ansari, R
    Govindan, R
    Janne, R
    Lilenbaum, R
    LUNG CANCER, 2005, 49 : S38 - S38
  • [44] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial
    Ngai, Yenting
    Hanna, Gerard
    Conibear, John
    Counsell, Nicholas
    Hughes, Laura
    Farrelly, Laura
    Landau, David
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1425 - S1426
  • [45] Linifanib treatment in patients with non-small cell lung cancer (NSCLC): Phase II results
    Soo, R. A.
    Goss, G. D.
    Salgia, R.
    Besse, B.
    Gandara, D. R.
    Hanna, N. H.
    Ricker, J. L.
    Qian, J.
    Carlson, D. M.
    Tan, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer
    Natale, RB
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 2 - 6
  • [47] Preliminary results from phase Ib study of spartalizumab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Santoro, A.
    Garrido Lopez, P.
    Tan, D. S. W.
    Paz-Ares, L.
    Shepherd, F.
    Bearz, A.
    Barlesi, F.
    Vansteenkiste, J. F.
    Kim, T. M.
    Overbeck, T. R.
    Rybkin, I. I.
    Felip, E.
    Zhou, W.
    Santarpia, L.
    Eddy, S.
    Schaefer, E. S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer
    Natale, RB
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 51 - 54
  • [49] A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC): Final results.
    Lilenbaum, R
    Bonomi, P
    Ansari, R
    Lynch, T
    Govindan, R
    Janne, P
    Hanna, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 629S - 629S
  • [50] PHASE II TRIAL: CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY WITH NITROGLYCERIN IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    De La Mata, Dolores
    Blake-Cerda, Monika
    Zamora, Jesus
    Pena, Omar
    Flores-Estrada, Diana
    Turcott, Jenny
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S133 - S134
12345